CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-09). The draft was written by AI, all 4 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 148 · Search date 2026-07-09 · Methodology v0.6

Black cohosh,
does it really help with Menopausal symptoms (hot flashes)?

30-Second Summary
D
Evidence Grade D · 33 · Safety warning
Evidence for menopausal hot flashes is weaker than many expect, and there is a liver-safety issue
What the
research shows
Black cohosh has long been used for menopausal hot flashes, but Cochrane review and a large independent RCT did not confirm clear improvement over placebo. Because liver-injury reports exist, safety is closer to a stronger warning than simple 'caution.'
What the
ads claim
Products use wording such as 'women's menopause,' 'hot flashes,' 'not a phytoestrogen,' and 'without hormone worries.' The actual evidence splits by extract type, and liver-safety wording is sometimes omitted.
*

Useful facts when choosing a product

  • Because cases of liver injury such as hepatitis, jaundice, and elevated liver enzymes have been reported, people with liver disease and people who drink heavily need particular caution.
  • Pregnant or breastfeeding people and people with hormone-sensitive conditions such as breast cancer are difficult to interpret without clinician consultation.
  • Verification of the original plant and issues of contamination or substitution differ by product and are important.
  • This should not be viewed as evidence for hot-flash improvement at the level of hormone therapy.
Gap Measurement · Verdict 148 · D 33
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Leach 2012 Cochrane review concluded from 16 RCTs and data on 2027 people that it was difficult to say black cohosh consistently improved hot-flash frequency or menopausal symptoms more than placebo. The Newton 2006 Ann Intern Med HALT study (n=351) found that black cohosh alone or in combined herbs did not reduce vasomotor symptoms more than placebo. Some commercial-extract studies such as Wuttke 2003 reported improvements in symptom scales, but they have manufacturer and formulation relevance.

02

Why this is classified as D (33)

Large independent RCT and Cochrane conclusions lean toward null or uncertainty, while positive evidence is strongly tied to formulation and industry. I judge it as the upper part of D, 33 points.

Counterpoint. A positive interpretation is possible when limited to some standardized extracts. However, once independent replication and safety are combined, it is appropriate to read the general claim low.

Rejudgment record. Draft — Large independent RCT and Cochrane found improvement in main symptoms uncertain; safety warning

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Leach MJ, Moore V. 2012Cochrane systematic review2027Non-profit review; original studies mixedHot-flash frequency and menopausal symptom scalesConcluded that consistent improvement versus placebo was difficult to confirm.Core
Newton KM et al. 2006Randomized placebo-controlled trial (HALT)351NCCAM/public fundingFrequency and intensity of vasomotor symptomsBlack cohosh alone and combined herbal products did not significantly reduce symptoms compared with placebo.Core counterexample
Naser B et al. 2011Safety reviewPossible links to commercial extractsLiver adverse eventsSummarized liver-injury case reports and debates over causality.Safety
§

Receipt — 4 References

Every cited source was opened and checked against the live page on 2026-07-09.

Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;CD007244. PMID: 22972105. DOI: 10.1002/14651858.CD007244.pub2.
checked
Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med. 2006;145:869-879. PMID: 17179056.
checked
NCCIH. Black Cohosh: Usefulness and Safety.
checked
Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol. 2008;66:758-766.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none

Cite this verdict

Black cohosh x menopausal symptoms (hot flashes) Evidence Grade D card
[Chamgap] Black cohosh x menopausal symptoms (hot flashes) — Evidence Grade D·33. 4 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/womens/black-cohosh-menopause-hot-flashes/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.